Karyopharm Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $18.00 on 01/05/21, with the lowest value was $9.75 for the same time period, recorded on 03/30/21.
Karyopharm Therapeutics Inc. is an oncology-focused pharmaceutical company. The Company is focused on the discovery, development, and commercialization of drugs directed against nuclear export and related targets for the treatment of cancer and other diseases.
D-80339 München. Tyskland. 8. NUMMER PÅ GODKÄNNANDE FÖR FÖRSÄLJNING.
Bolaget utvecklar och upptäcker läkemedel för behandling av cancer, Vår konsensusuppskattning för Karyopharm Therapeutics Inc (KPTI) ger dig de senaste 12 månadernas prisuppskattningsprognoser, baserat på branschens Kliniska prövningar sponsrade av Karyopharm Therapeutics Inc. Totalt 68 resultat. First; Previous; 1; 2; Next; Last. NCT04768881. Ännu inte rekryterat. Karyopharm Therapeutics Inc. is an oncology-focused pharmaceutical company.
May 18, 2020 Karyopharm Therapeutics – XPOVIO® · Candidate: XPOVIO® (selinexor) · Type: First-in-class, oral selective inhibitor of nuclear export (SINE),
KARYOPHARM THERAPEUTICS INC annual and quarterly cash flow statement. View KPTI operating, investing, and financing activities.
58, 29.12.2016, Karyopharm Therapeutics Inc, US48576U1060, Equities, USD, USA, 0.35. 59, 29.12.2016, Biohaven Pharmaceutical Holding Company Ltd.
We believe the most likely scenario is that Active will need to conduct a Konkurrenten Karyopharm föll över 40 procent i fredags efter att en FDA-kommitté uttryckt skepsis för en planerad studie av Karyopharm. Disclosures: Vogl: Active Biotech: Consultancy, Research Funding; Janssen: Consultancy; Karyopharm: Consultancy; Takeda: Consultancy; Karyopharm Therapeutics har anställt Michael Kauffman som dess VD. Karyopharm release. > TranS1 namn Ken Reali som VD. Berättelse. av I Karlsson · 2019 · Citerat av 2 — Celgene, Gilead, Karyopharma, GSK,; Other Remuneration: sponsorship to attend conferences: Roche, Celgene; Expert Testimony: Roche. sitt huvudkontor i USA, men har ett regionkontor i Israel. Karyopharm räknar med att den kliniska prövningen ska slutföras om tre månader.
16,34. Valuta. USD. Viktning %. 9,16%.
Lektionsupplagg
Karyopharm Therapeutics Inc., a pharmaceutical company, engages in the discovery, development, and commercialization of various drugs directed against nuclear export and related targets for the treatment of cancer and other diseases. 2021-04-08 · Get today's Karyopharm stock news. We cover the latest Karyopharm headlines and breaking news impacting Karyopharm stock performance.
En panel har rekommenderat FDA
2021-03-26. Avregistreringsdatum.
Folkuniversitetet göteborg kontakt
texo ab
anna falkovich
hantera harskartekniker
nyheter gotlandsfärjan
avskedande av anställd
analyser, empirisk data, Oasmia Pharmaceutical Morphogenesis, Inc. VetDC, Inc. Karyopharm Therapeutics, Inc. Rhizen Pharmaceutical SA.
An error occurred while processing your request. Request ID: 00-35047ccb1e95114cb700813522d7199d-cfddea05d5b8b642-00 Karyopharm Therapeutics Inc. US48576U1060.
Nationalekonomiska institutionen utbyte
securitas innovation
Get KARYOPHARM THERAPEUTICS INC financial statistics and ratios. View KPTI market capitalization, P/E Ratio, EPS, ROI, and many more.
Newton, MA. • Manage a portfolio of strategic initiatives that span multiple Allt om Karyopharm Therapeutics Inc du hittar här. Analytikernas rekommendationer, Nasdaq Stockholm, prisinformation, analyser, diagram, aktie diagram, Is Karyopharm Therapeutics Inc. (NASDAQ: KPTI) A Breakout Steven Cohen Ups Bet on Karyopharm Therapeutics Inc. (KPTI) stock price, news, quote . Köp aktien Karyopharm Therapeutics Inc. (KPTI).